CC
AMGN icon

Curian Capital’s Amgen AMGN Stock Holding History

Curian Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19,816
Closed -$3.22M – 20
2015
Q4 		$3.22M Sell
19,816
-39,131
-66% -$6.15M 0.24% 92
2015
Q3 		$8.15M Buy
58,947
+53,554
+993% +$8.44M 0.22% 113
2015
Q2 		$828K Sell
5,393
-642
-11% -$103K 0.01% 494
2015
Q1 		$965K Sell
6,035
-5,799
-49% -$913K 0.02% 470
2014
Q4 		$1.89M Buy
11,834
+170
+1% +$26.5K 0.03% 309
2014
Q3 		$1.64M Sell
11,664
-24,791
-68% -$3.24M 0.03% 332
2014
Q2 		$4.32M Sell
36,455
-15,938
-30% -$1.84M 0.08% 231
2014
Q1 		$6.46M Buy
52,393
+39,264
+299% +$4.76M 0.11% 201
2013
Q4 		$1.5M Buy
13,129
+2,647
+25% +$301K 0.03% 324
2013
Q3 		$1.17M Buy
10,482
+403
+4% +$43.7K 0.02% 354
2013
Q2 		$994K Buy
+10,079
New +$1.05M 0.02% 369

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Curian Capital's AMGN Position: Q1 2016 in Review

Curian Capital sold out of Amgen (AMGN) in Q1 2016, closing a stake of 19,816 shares — an estimated $3.22M sold.

Curian Capital first reported a position in AMGN in Q2 2013 and held it in 11 quarters. The position peaked at $8.15M in Q3 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Curian Capital reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 19,816 Amgen shares in Q1 2016, an estimated $3.22M.
  • Curian Capital first reported a position in Amgen in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Amgen position peaked at $8.15M in Q3 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.